Tempest Therapeutics, Inc.
TPST
$1.08
$0.032.86%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/26/2026
-
TipRanks: TheFly
6/12/2026
-
The Cerbat Gem
6/4/2026
-
Globe Newswire
6/2/2026
-
TipRanks Financial Blog
5/29/2026
-
TipRanks Financial Blog
5/29/2026
-
Globe Newswire
5/22/2026
-
TipRanks Financial Blog
5/18/2026
-
The Cerbat Gem
5/16/2026
-
The Cerbat Gem
5/14/2026
-
The Cerbat Gem
5/14/2026
-
Seeking Alpha - Healthcare
5/14/2026
-
Globe Newswire
5/6/2026
-
TipRanks Financial Blog
5/6/2026
-
Globe Newswire
4/29/2026
-
Globe Newswire
4/22/2026
-
Globe Newswire
4/14/2026
-
Globe Newswire
4/10/2026
-
Zacks Investment Research
4/2/2026
-
TipRanks Financial Blog
3/30/2026
-
TipRanks Financial Blog
3/30/2026
-
Globe Newswire
3/28/2026
-
Ticker Report
3/26/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 30, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
415 798 8589
Address
2000 Sierra Point Parkway
Brisbane, CA 94005
Brisbane, CA 94005
Country
Year Founded
--
Business Description
Sector
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule...
more